Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)

Published:2021-08-08 Issue: Volume: Page:
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Buelens Sarah¹²^ORCID,Poelaert Filip¹²^ORCID,Claeys Tom¹²,De Bleser Elise¹²^ORCID,Dhondt Bert¹²^ORCID,Verla Wesley¹,Ost Piet³^ORCID,Rappe Bernard⁴,De Troyer Bart⁵,Verbaeys Caroline⁶,Kimpe Bart⁷,Billiet Ignace⁸,Plancke Hendrik⁹,Fransis Karen¹⁰,Willemen Patrick¹¹,Ameye Filip¹²,Decaestecker Karel¹,Lumen Nicolaas¹²^ORCID

Affiliation:

1. Department of Urology Ghent University Hospital GhentBelgium

2. Cancer Research Institute Ghent Ghent University Ghent Belgium

3. Department of Radiation Oncology Ghent University Hospital GhentBelgium

4. Department of Urology ASZ AalstBelgium

5. Department of Urology AZ Nikolaas Sint‐NiklaasBelgium

6. Department of Urology AZ Jan Palfijn GhentBelgium

7. Department of Urology Sint‐Lucas Hospital BrugesBelgium

8. Department of Urology AZ Groeninge KortrijkBelgium

9. Department of Urology Imelda Hospital BonheidenBelgium

10. Department of Urology University Hospital Antwerp AntwerpBelgium

11. Department of Urology Jessa Hospital GhentBelgium

12. Department of Urology AZ Maria Middelares Ghent Belgium

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15553

Reference41 articles.

1. EAU‐EANM‐ESTRO‐ESUR‐SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer;Cornford P;Eur Urol,2021

2. Studies on prostatic cancer;Huggins C;Arch Surg,1941

3. Survival with newly diagnosed metastatic prostate cancer in the? docetaxel era?: data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019);James ND;Eur Urol,2015

4. Chemohormonal therapy in metastatic hormone‐sensitive prostate cancer;Sweeney CJ;N Engl J Med,2015

5. Addition of docetaxel, zoledronic acid, or both to first‐line long‐term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James ND;Lancet,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival benefit of radical prostatectomy in patients with advanced TURP-diagnosed prostate cancer: a population-based real-world study;BMC Surgery;2024-05-03

2. Role of cytoreductive radical prostatectomy in men with oligometastatic prostate cancer on molecular imaging;Current Opinion in Urology;2024-04-05

3. Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer;Frontiers in Oncology;2024-03-13

4. Current evidence on local therapy in oligometastatic prostate cancer;Current Opinion in Urology;2024-02-01

5. A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy;IJU Case Reports;2024-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3